Haematologic Technologies, Inc.

Essex Junction, VT 05452

SBIR Award Summary

Total Number of Awards 17
Total Value of Awards $1.96MM
First Award Date 12/01/88
Most Recent Award Date 07/01/08

Key Personnel

Last Name Name Awards Contact
Jenny Richard J. Jenny 13
Haley Paul E Haley 1
Dorfman Ryan H Dorfman 3

17 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-06-21
Budget: 07/01/08 - 06/30/10

DESCRIPTION (provided by applicant): Phase I funding for this project supported successful studies that were aimed at demonstrating the feasibility of developing an easy to use, global test in the arena of clinical hemostasis that would be sensitive to antithrombotic drugs, bleeding disorders and thrombotic pathologies. This test comprises a mea...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-06-21
Budget: 07/20/07 - 06/30/08

DESCRIPTION (provided by applicant): Phase I funding for this project supported successful studies that were aimed at demonstrating the feasibility of developing an easy to use, global test in the arena of clinical hemostasis that would be sensitive to antithrombotic drugs, bleeding disorders and thrombotic pathologies. This test comprises a mea...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/06 - 08/31/08

DESCRIPTION (provided by applicant): Factor VIIa and tissue factor (TF) are essential proteins for the initiation of blood coagulation. Blood coagulation is initiated when cryptic TF becomes exposed on the surface of vascular cells where it can bind circulating factor VIla. The factor Vlla/TF complex catalyzes the activation of certain blood zym...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 12/01/05 - 11/30/07

DESCRIPTION (provided by applicant): The mechanisms that govern blood coagulation and fibrinolysis have been studied extensively by employing a variety of experimental techniques and in-vivo model systems. Recently gene targeting (knockout mice) and transgenic techniques have been employed to create strains of mice whose phenotypes represent hum...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/05 - 08/31/06

DESCRIPTION (provided by applicant): Factor VIIa and tissue factor (TF) are essential proteins for the initiation of blood coagulation. Blood coagulation is initiated when cryptic TF becomes exposed on the surface of vascular cells where it can bind circulating factor VIla. The factor Vlla/TF complex catalyzes the activation of certain blood zym...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/15/05 - 11/30/05

DESCRIPTION (provided by applicant): The mechanisms that govern blood coagulation and fibrinolysis have been studied extensively by employing a variety of experimental techniques and in-vivo model systems. Recently gene targeting (knockout mice) and transgenic techniques have been employed to create strains of mice whose phenotypes represent hum...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 08/16/04 - 11/15/05

DESCRIPTION (provided by applicant): Although the vast majority of patients who suffer from venous or arterial thrombosis have haemostatic systems that fall within the "normal" range of routine screening tools such as PT, aPTT, and factor assays, thrombosis is the major cause of death in Western countries. In contrast, the propensity to bleed (i...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/15/03 - 01/15/04

DESCRIPTION (provided by applicant): The mechanisms that govern blood coagulation and fibrinolysis have been studied extensively by employing a variety of experimental techniques and in-vivo model systems. Recently gene targeting (knockout mice) and transgenic techniques have been employed to create strains of mice whose phenotypes represent hum...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/08/03 - 10/31/03

DESCRIPTION (provided by applicant): Factor Vlla and Tissue Factor (TF) are essential proteins for the initiation of blood coagulation. Blood coagulation is initiated when cryptic TF becomes exposed on the surface of vascular cells where it can bind circulating factor Vlla. The factor Vlla/TF complex catalyzes the activation of certain blood zym...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/94 - 03/14/95

In the area of clinical coagulation research, much attention is focused on the molecular events which occur before, during, and after anticoagulant and antithrombotic therapies. For purposes of monitoring the safety, efficacy and long-term effects of such therapies, there exist a number of commercially available assays to assess the progression ...

Load More